Skip to main content
TipRanks
Go Ultimate75% OFF

Todd P. Branning Insider Profile

4 Followers

Todd P. Branning, Chief Financial Officer at Phathom Pharmaceuticals, holds ― shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 84.20K shares in NeuBase Therapeutics (Ticker: NBSE), holds 12.79K shares in Amneal Pharmaceuticals (Ticker: AMRX).

Todd P. Branning's Trading History

NBSE
NeuBase Therapeutics
Mar 17, 2023―Uninformative Buy―$31.83K
AMRX
Amneal Pharmaceuticals
Jan 23, 2020SVP and CFOUninformative Buy65.59K$273.34K
PHAT
Phathom Pharmaceuticals
―Chief Financial Officer――

You May Also Like

Todd P. Branning insider profile FAQ

What is the percentage of profitable transactions made by Todd P. Branning?
The percentage of profitable transactions made by Todd P. Branning is 0%.
What is the average return per transaction made by Todd P. Branning?
The average return per transaction made by Todd P. Branning is -89.70%.
What stocks does Todd P. Branning hold?
Todd P. Branning holds: PHAT, NBSE, AMRX stocks.
What was Todd P. Branning's most profitable transaction?
Todd P. Branning’s most profitable transaction was an Informative Buy of NBSE stock on March 18, 2022. The return on the trade was -89.40%.
What is Todd P. Branning's role in Phathom Pharmaceuticals?
Todd P. Branning's role in Phathom Pharmaceuticals is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.